---
figid: PMC3660516__nihms440394f4
figlink: /pmc/articles/PMC3660516/figure/F4/
number: F4
caption: In vitro and animal studies have shown that statins exert antineoplastic
  effects through both HMG-CoA reductase-dependent and HMG-CoA reductase-independent
  pathways. The primary mechanism of action of statins on cholesterol reduction is
  by competitive inhibition of HMG-CoA reductase, the rate limiting step in cholesterol
  biosynthesis, blocking the conversion of HMG-CoA into mevalonate. Consequently,
  statins can inhibit several of the downstream products of the mevalonate pathway
  including the generation of isoprenoids. This prevents post-translational prenylation
  of small signaling G-proteins of the Ras/Rho/Rac superfamily, which are important
  mediators of cell growth, differentiation and survival. They also exert pro-apoptotic
  effects through regulation of Rho and RAF-mitogen activated protein kinase 1-extracellular
  regulated kinase (MEK-ERK) pathway through a HMG-CoA reductase dependent mechanism,
  by activating caspases and decreasing Bcl-2.,  Statins inhibit the activation of
  the proteosome pathway, limiting the breakdown of cyclin-dependent kinase inhibitors
  p21 and p27, thus allowing these molecules to exert their growth-inhibitory effects.
  In addition, they also exert an anti-inflammatory and immunomodulatory effects,
  modifying the cell adhesion cascade through both HMG-CoA reductase-dependent and
  HMG-CoA reductase-independent effects.
pmcid: PMC3660516
papertitle: 'Statins Are Associated with Reduced Risk of Esophageal Cancer, Particularly
  in Patients with Barrett’s Esophagus: A Systematic Review and Meta-Analysis.'
reftext: Siddharth Singh, et al. Clin Gastroenterol Hepatol. ;11(6):620-629.
pmc_ranked_result_index: '46185'
pathway_score: 0.9122909
filename: nihms440394f4.jpg
figtitle: 'Statins Are Associated with Reduced Risk of Esophageal Cancer, Particularly
  in Patients with Barrett’s Esophagus: A Systematic Review and Meta-Analysis'
year: ''
organisms: Homo sapiens
ndex: 708dc026-df10-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3660516__nihms440394f4.html
  '@type': Dataset
  description: In vitro and animal studies have shown that statins exert antineoplastic
    effects through both HMG-CoA reductase-dependent and HMG-CoA reductase-independent
    pathways. The primary mechanism of action of statins on cholesterol reduction
    is by competitive inhibition of HMG-CoA reductase, the rate limiting step in cholesterol
    biosynthesis, blocking the conversion of HMG-CoA into mevalonate. Consequently,
    statins can inhibit several of the downstream products of the mevalonate pathway
    including the generation of isoprenoids. This prevents post-translational prenylation
    of small signaling G-proteins of the Ras/Rho/Rac superfamily, which are important
    mediators of cell growth, differentiation and survival. They also exert pro-apoptotic
    effects through regulation of Rho and RAF-mitogen activated protein kinase 1-extracellular
    regulated kinase (MEK-ERK) pathway through a HMG-CoA reductase dependent mechanism,
    by activating caspases and decreasing Bcl-2.,  Statins inhibit the activation
    of the proteosome pathway, limiting the breakdown of cyclin-dependent kinase inhibitors
    p21 and p27, thus allowing these molecules to exert their growth-inhibitory effects.
    In addition, they also exert an anti-inflammatory and immunomodulatory effects,
    modifying the cell adhesion cascade through both HMG-CoA reductase-dependent and
    HMG-CoA reductase-independent effects.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CCNE1
  - CCND3
  - PDGFA
  - CCND1
  - FGF16
  - FGF14
  - CCNE2
  - CCND2
  - CASP10
  - CASP8
  - CASP9
  - FGF18
  - FGF17
  - MAP2K2
  - FGF7
  - CASP12
  - FGF9
  - CASP1
  - CASP2
  - FGF20
  - FGF21
  - CASP5
  - CASP6
  - CASP7
  - FGF23
  - ARAF
  - FGF4
  - FGF5
  - FGF19
  - RAF1
  - NFKB1
  - PI3
  - CASP3
  - CASP4
  - MAP2K1
  - BRAF
  - VEGFA
  - FGF22
  - VEGFB
  - VEGFC
  - FGF10
  - FGF8
  - FGF12
  - CASP14
  - PGF
  - FGF11
  - MAPK1
  - FGF13
  - FGF3
  - FGF1
  - FGF6
  - FGF2
  - AKT1
  - MAPK3
  - KRAS
  - PDGFB
  - HRAS
  - PDGFD
  - VEGFD
  - PDGFC
  - NRAS
  - RHOD
  - RAC1
  - Mevalonate
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
genes:
- word: CyclinD/E
  symbol: Cyclin_E
  source: bioentities_symbol
  hgnc_symbol: CCNE1
  entrez: '898'
- word: CyclinD/E
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND3
  entrez: '896'
- word: VEGF/PDGF/FGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFA
  entrez: '5154'
- word: CyclinD/E
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: VEGF/PDGF/FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF16
  entrez: '8823'
- word: VEGF/PDGF/FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF14
  entrez: '2259'
- word: CyclinD/E
  symbol: Cyclin_E
  source: bioentities_symbol
  hgnc_symbol: CCNE2
  entrez: '9134'
- word: CyclinD/E
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND2
  entrez: '894'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: VEGF/PDGF/FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF18
  entrez: '8817'
- word: VEGF/PDGF/FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF17
  entrez: '8822'
- word: Raf/MEK/ERK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: VEGF/PDGF/FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF7
  entrez: '2252'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: VEGF/PDGF/FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF9
  entrez: '2254'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: VEGF/PDGF/FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF20
  entrez: '26281'
- word: VEGF/PDGF/FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF21
  entrez: '26291'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: VEGF/PDGF/FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF23
  entrez: '8074'
- word: Raf/MEK/ERK
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: VEGF/PDGF/FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF4
  entrez: '2249'
- word: VEGF/PDGF/FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF5
  entrez: '2250'
- word: VEGF/PDGF/FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF19
  entrez: '9965'
- word: Raf/MEK/ERK
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: PI3/AKT1
  symbol: PI3
  source: hgnc_symbol
  hgnc_symbol: PI3
  entrez: '5266'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
- word: Raf/MEK/ERK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: Raf/MEK/ERK
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: VEGF/PDGF/FGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: VEGF/PDGF/FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF22
  entrez: '27006'
- word: VEGF/PDGF/FGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF/PDGF/FGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: VEGF/PDGF/FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF10
  entrez: '2255'
- word: VEGF/PDGF/FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF8
  entrez: '2253'
- word: VEGF/PDGF/FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF12
  entrez: '2257'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: VEGF/PDGF/FGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: VEGF/PDGF/FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF11
  entrez: '2256'
- word: Raf/MEK/ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: VEGF/PDGF/FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF13
  entrez: '2258'
- word: VEGF/PDGF/FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF3
  entrez: '2248'
- word: VEGF/PDGF/FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF1
  entrez: '2246'
- word: VEGF/PDGF/FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF6
  entrez: '2251'
- word: VEGF/PDGF/FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF2
  entrez: '2247'
- word: PI3/AKT1
  symbol: AKT1
  source: hgnc_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Raf/MEK/ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: VEGF/PDGF/FGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFB
  entrez: '5155'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: VEGF/PDGF/FGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFD
  entrez: '80310'
- word: VEGF/PDGF/FGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: VEGF/PDGF/FGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFC
  entrez: '56034'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Rho/Rac1
  symbol: Rho
  source: hgnc_alias_symbol
  hgnc_symbol: RHOD
  entrez: '29984'
- word: Rho/Rac1
  symbol: RAC1
  source: hgnc_symbol
  hgnc_symbol: RAC1
  entrez: '5879'
chemicals:
- word: Mevalonate
  source: MESH
  identifier: D008798
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC3660516__F4
redirect_from: /figures/PMC3660516__F4
figtype: Figure
---
